U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836088) titled 'A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases' on Sept. 14.
Brief Summary: This study aims to evaluate the clinical value of multimodal ultrasound for assessing muscle mass in patients with metabolic diseases, including metabolic syndrome, type 2 diabetes, and simple obesity. Skeletal muscle is the largest metabolic organ in the human body and plays a critical role in glucose metabolism. Muscle mass reduction is common in patients with metabolic diseases and is associated with insulin resistance, poor disease control, and increased risk of complications. Currently available methods for ...